| http://www.w3.org/ns/prov#value | - The components of the pharmaceutical compositions also are capable of being co-mingled with the hyaluronic acid, analog, or other agent that binds to the hyaluronic acid binding region of CD44 , and with each other, in a manner such that there is no interaction which would substantially impair the desired pharmaceutical efficacy. [0101] The pharmaceutical compositions may contain suitable bufferin
|
